New Cousteau-Linked...
Anika Therapeutics Inc. (ANIK: NASDAQ)
$13.01 -0.59 | -4.34%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 17.60 | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | 50.00 | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | 8.50 | n.a. | 12.50 |
| Beta | 1.45 | 0.58 | 0.98 |
| Price to Sales (TTM) | 2.66 | 4.62 | 1.42 |
| Price to Book (MRQ) | 1.82 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 2.72 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | 12.70 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | 31.70 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 22.30 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 16.60 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 19.68 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 489.40 | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 489.40 | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | 4.01 | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -12.19 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.00 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 5.00 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.09 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.11 | 0.45 | 0.96 |
| Interest Coverage (TTM) | 85.50 | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 65.10 | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 65.40 | 83.50 | 47.70 |
| EBITD Margin (TTM) | 30.50 | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | 18.88 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 24.20 | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 17.60 | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.15 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 11.50 | 5.30 | 7.00 |
| Return on Assets (TTM) | 7.50 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | 4.60 | 2.20 | 2.50 |
| Return on Investment (TTM) | 9.40 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | 6.40 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 522,493.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | 77,941.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | 4.60 | 5.80 | 7.60 |
| Inventory Turnover (TTM) | 2.60 | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.50 | 0.40 | 0.40 |
Portfolios with ANIK
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserTrade Growth
- Userbfab Portfolio 1
- Usersome mad buggers wall
- Usermjaquillard Portfolio 1
- UserJenaLoren Stocks
- Usermagic formula cws
- UserLittle Nicky's Pop
Latest ANIK Headlines from TheStreet
- Anika Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.04.12 | 12:05 pm
- 8 Stocks Rising on Unusual Volume 04.09.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 04.02.12 | 01:04 pm
- 8 Stocks Rising on Monster Volume 03.21.12 | 02:03 pm
- Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.01.12 | 06:03 pm
- Anika Therapeutics Inc. Stock Upgraded (ANIK) 11.15.11 | 06:11 am
- Anika Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 02:11 pm
- Anika Stock Soars (ANIK) 11.03.11 | 09:11 am
- Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.05.11 | 02:08 pm
- Anika Therapeutics Inc. Stock Downgraded (ANIK) 05.09.11 | 08:05 am
Press Releases for ANIK
- Anika Therapeutics Announces Date Of First-Quarter 2012 Financial Results Conference Call - Business Wire 04.26.12 | 08:04 am
- Anika Therapeutics Reports 25% Increase In Fourth-Quarter Revenue - Business Wire 02.29.12 | 05:02 pm
- Anika Therapeutics Announces Date Of Fourth-Quarter And Year-End 2011 Financial Results Conference Call - Business Wire 02.23.12 | 09:02 am
- Anika Therapeutics To Present At The Canaccord Genuity Musculoskeletal Conference On February 7 - Business Wire 02.02.12 | 01:02 pm
- Anika Therapeutics To Present At The Eighth Annual Noble Financial Equity Conference On January 17 - Business Wire 01.10.12 | 10:01 am
- Anika Therapeutics Announces U.S. MONOVISC® License And Supply Agreement With DePuy Mitek, Inc. - Business Wire 12.21.11 | 03:12 pm
- Anika Therapeutics To Present At The LD Micro Conference On December 8 - Business Wire 11.30.11 | 11:11 am
- Anika Therapeutics To Present At The Security Research Associates 7th Annual Fall Growth Stock Conference On November 15 - PR Newswire 11.15.11 | 08:11 am
- Anika Therapeutics To Present At The Security Research Associates 7th Annual Fall Growth Stock Conference On November 15 - PR Newswire 11.10.11 | 08:11 am
- Anika Therapeutics Reports 33% Revenue Growth In Third Quarter 2011 - Business Wire 11.02.11 | 04:11 pm
Partner Headlines for ANIK
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.30.12 | 09:05 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 05.25.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.23.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.17.12 | 09:05 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 05.10.12 | 09:05 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.08.12 | 09:05 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 04.25.12 | 09:04 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 04.20.12 | 09:04 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 04.16.12 | 09:04 am
- Two Stocks Crossing Over Their 50 Day Moving Averages (ANIK, EKB) - Benzinga 11.30.10 | 01:11 pm





